Evidence map›Paper›PMID 38043095›Full record

ArticleJournal of proteome research2024

Defining Distinct RNA-Protein Interactomes of SARS-CoV-2 Genomic and Subgenomic RNAs.

Isabella T Whitworth, Rachel A Knoener, Maritza Puray-Chavez, Peter Halfmann, Sofia Romero, M'bark Baddouh, Mark Scalf, Yoshihiro Kawaoka, Sebla B Kutluay, Lloyd M Smith and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Isabella T WhitworthDepartment of Chemistry, University of Wisconsin-Madison College of Letters and Sciences, Madison, Wisconsin 53706, United States.ORCID 0000-0001-9753-5666
Rachel A KnoenerDepartment of Chemistry, University of Wisconsin-Madison College of Letters and Sciences, Madison, Wisconsin 53706, United States.ORCID 0000-0002-2787-1098
Maritza Puray-ChavezDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Peter HalfmannInfluenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53705, United States.
Sofia RomeroMcArdle Laboratory for Cancer Research and Carbone Cancer Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin 53705, United States.
M'bark BaddouhMcArdle Laboratory for Cancer Research and Carbone Cancer Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin 53705, United States.
Mark ScalfDepartment of Chemistry, University of Wisconsin-Madison College of Letters and Sciences, Madison, Wisconsin 53706, United States.
Yoshihiro KawaokaInfluenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53705, United States.
Sebla B KutluayDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Lloyd M SmithDepartment of Chemistry, University of Wisconsin-Madison College of Letters and Sciences, Madison, Wisconsin 53706, United States.
Nathan M ShererMcArdle Laboratory for Cancer Research and Carbone Cancer Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin 53705, United States.
University of Wisconsin–Madison · USWashington University in St. Louis · US

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
The Cell Biology of HIV-1 Genome TraffickingR01AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Nathan M Sherer · 2014 to 2026
$4.4M
Sequence-specific Hybridization Capture to Reveal the lncRNA Interactome in Prostate CancerR01CA193481 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DAVID F. JARRARD, Lloyd M Smith · 2015 to 2026
$3.4M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
NCI NIH HHS R01 CA193481NHGRI NIH HHS T32 HG002760NIAID NIH HHS 75N93021C00014NIAID NIH HHS R01 AI110221NIAID NIH HHS T32 AI078985NIAID NIH HHS U54 AI170660NIGMS NIH HHS T32 GM008349
6 · The paper itself

Abstract

Host RNA binding proteins recognize viral RNA and play key roles in virus replication and antiviral mechanisms. SARS-CoV-2 generates a series of tiered subgenomic RNAs (sgRNAs), each encoding distinct viral protein(s) that regulate different aspects of viral replication. Here, for the first time, we demonstrate the successful isolation of SARS-CoV-2 genomic RNA and three distinct sgRNAs (N, S, and ORF8) from a single population of infected cells and characterize their protein interactomes. Over 500 protein interactors (including 260 previously unknown) were identified as associated with one or more target RNA. These included protein interactors unique to a single RNA pool and others present in multiple pools, highlighting our ability to discriminate between distinct viral RNA interactomes despite high sequence similarity. Individual interactomes indicated viral associations with cell response pathways, including regulation of cytoplasmic ribonucleoprotein granules and posttranscriptional gene silencing. We tested the significance of three protein interactors in these pathways (APOBEC3F, PPP1CC, and MSI2) using siRNA knockdowns, with several knockdowns affecting viral gene expression, most consistently PPP1CC. This study describes a new technology for high-resolution studies of SARS-CoV-2 RNA regulation and reveals a wealth of new viral RNA-associated host factors of potential functional significance to infection.

Indexed as

COVID-19SARS-CoV-2GenomicsHumansRNA-Binding ProteinsRNA, ViralSubgenomic RNAVirus ReplicationMSI2 protein, humanRNA-Binding ProteinsRNA, ViralSubgenomic RNAcoronaviruseshost−pathogen interactionsRNA binding proteinsRNA-protein interactionsSARS-CoV-2subgenomic RNAviral proteomics

Identifiers

PMID38043095
PMCPMC10804885
OpenAlexW4389287023

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.